Emily Merullo (Willhoft) has a strong background in accounting, with experience working in various positions at companies such as Karyopharm Therapeutics Inc., Sage Therapeutics, Extreme Reach, and PwC. Emily is currently serving as an Associate Director in the Accounting department at Karyopharm Therapeutics Inc. Emily also has a Master of Science in Accounting and Taxation, Financial and Assurance Services from the University of Hartford. Emily has expertise in fixed assets, bank reconciliations, budgets, and general ledger management.
January 1, 2024 - present
January, 2022
March, 2021
June, 2020